A Oneindia Venture

Pine Labs IPO Subscribed Just 12% on Day 1; GMP Remains Flat with 2.2% Listing Gains Expected

The Pine Labs IPO opened for subscription today, on November ,7 but experienced a slow start on the first day of bidding. According to data available on the NSE, the Pine Labs IPO was subscribed just 0.12 times (12%) as of 3:59 PM, a muted response from investors despite the company's strong anchor book and growing dominance in the fintech space.

Pine Labs IPO Subscribed Just 12% on Day 1; GMP Remains Flat with 2.2% Listing G

Weak Start to Subscription

The public issue of Pine Labs Ltd attracted mild interest from retail investors, while institutional participation was yet to pick up. By the end of Day 1, the retail category was subscribed 0.53 times (53%), the non-institutional investor (NII) segment stood at 0.06 times, and the qualified institutional buyer (QIB) portion (excluding anchors) recorded no bids yet. The issue will remain open till November 11.

Grey Market Premium Stays Muted

In the grey market, the Pine Labs IPO GMP (Grey Market Premium) remained flat at Rs. 5 as of November 7, 2025, 2:54 PM, as per data from the Investorgain website. Based on the upper price band of Rs. 221, the expected listing price is around Rs. 226, implying a potential listing gain of just 2.26%.

IPO Structure and Key Details

The Rs. 3,899.91 crore public issue is a book-built IPO, comprising a fresh issue of Rs. 2,080 crore (9.41 crore shares) and an offer for sale (OFS) of Rs. 1,819.91 crore (8.23 crore shares) by existing shareholders. The price band is set between Rs. 210 and Rs. 221 per share, with a lot size of 67 shares per application. Retail investors require a minimum investment of Rs. 14,807, while small and big HNIs need to invest Rs. 2.07 lakh and Rs. 10.06 lakh, respectively, depending on lot size.

The IPO also includes a special reservation of 125,000 shares for employees, offered at a discount of Rs. 21 per share, making it more attractive for internal stakeholders.

Ahead of its public issue, Pine Labs successfully raised Rs. 1,753.83 crore from anchor investors on November 6.
Key IPO Dates and Listing Plan

The basis of allotment is expected on November 12, with refunds and Demat transfers on November 13 and a tentative listing date of November 14 on both BSE and NSE.

Should You Subscribe to the Issue?

SBI Securities in its report said, "The company has built long-lasting relationships with marquee clients like HDFC Bank, Croma, LG Electronics, etc., and is ready to capitalise on the ~Rs 276 trillion market opportunity by FY29P. Between FY23 and FY25, it has delivered a healthy revenue/EBITDA CAGR of 19.3%/538.6%, respectively. Furthermore, the company plans to repay debt of Rs 532 crore through the proceeds from the IPO. The company's operations have witnessed a turnaround with robust growth in EBITDA and adj EBITDA during the FY23-FY25 period. On the back of a robust business model, going forward, we believe the company is well placed to deliver profitable growth, and hence, we recommend investors SUBSCRIBE to the issue with a long-term investment horizon."

About Pine Labs Limited

Founded in 1998 and headquartered in Noida, Pine Labs Limited is one of India's leading fintech companies, offering digital payment and merchant commerce solutions. The company began as a petroleum retail automation firm before evolving into a major provider of Android-based Point-of-Sale (POS) systems and digital transaction technologies.
Today, Pine Labs serves a vast network of merchants, enterprises, and financial institutions across India, Malaysia, the UAE, Singapore, Australia, the US, and Africa. Its services include digital payments, transaction processing, consumer financing, loyalty programmes, and prepaid card solutions.

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+